Scott Applebaum
Director/Board Member at The Boys & Girls Clubs of Philadelphia
Scott Applebaum active positions
Companies | Position | Start | End |
---|---|---|---|
The Boys & Girls Clubs of Philadelphia | Director/Board Member | - | - |
Career history of Scott Applebaum
Former positions of Scott Applebaum
Companies | Position | Start | End |
---|---|---|---|
CINGULATE INC. | Director/Board Member | 2022-08-08 | 2023-12-05 |
Independent Dir/Board Member | 2022-08-08 | 2023-12-05 | |
TREVENA, INC. | Compliance Officer | 2020-02-12 | 2021-08-30 |
General Counsel | 2020-02-12 | 2021-08-30 | |
Corporate Secretary | - | 2021-08-30 | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | President | 2017-08-31 | 2019-05-31 |
VITAE PHARMACEUTICALS INC | General Counsel | 2016-06-30 | 2016-11-30 |
Corporate Secretary | 2016-06-30 | 2016-11-30 | |
AEVI GENOMIC MEDICINE, INC. | General Counsel | 2014-09-09 | 2016-06-30 |
Corporate Secretary | 2014-09-09 | 2016-06-30 | |
SHIRE | Compliance Officer | - | - |
General Counsel | - | - | |
Corporate Officer/Principal | 2014-08-31 | 2016-05-31 | |
Bristol-Myers Squibb SA (Switzerland) | General Counsel | - | - |
VECTIVBIO HOLDING AG | General Counsel | 2021-09-07 | - |
Corporate Secretary | 2021-09-07 | - |
Training of Scott Applebaum
Stanford Law School | Graduate Degree |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistics
International
United States | 9 |
Switzerland | 3 |
Ireland | 2 |
Operational
General Counsel | 6 |
Corporate Secretary | 4 |
Director/Board Member | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
TREVENA, INC. | Health Technology |
CINGULATE INC. | Health Technology |
Private companies | 7 |
---|---|
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
The Boys & Girls Clubs of Philadelphia | |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
Bristol-Myers Squibb SA (Switzerland) |
- Stock Market
- Insiders
- Scott Applebaum
- Experience